Observational analysis found a positive correlation between galectin 3 levels and diastolic dysfunction in asymptomatic cancer survivors, indicating potential for screening.
Key Points
Galectin 3 significantly correlates with diastolic dysfunction, suggesting its role as a biomarker.
E/e’ ratio showed a correlation coefficient of r = 0.37 with p = 0.04, emphasizing its potential utility.
The study included 30 asymptomatic survivors averaging 24.9 years old with a mean time since treatment of 13.5 years.
Findings highlight the need for larger prospective studies to further validate galectin 3's diagnostic value.